| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |